The nature, time course and severity of methamphetamine withdrawal

Discipline of Clinical and Experimental Pharmacology, University of Adelaide, Tarndarnya, South Australia, Australia
Addiction (Impact Factor: 4.6). 10/2005; 100(9):1320-9. DOI: 10.1111/j.1360-0443.2005.01160.x
Source: PubMed

ABSTRACT To characterize the natural history of methamphetamine withdrawal during the first 3 weeks of abstinence.
Cross-sectional study with comparison group. Setting A substance use treatment facility in Chiang Mai Province, Thailand.
The sample comprised 21 in-patients undergoing treatment for methamphetamine dependence. Nine age- and sex-matched non-dependent individuals provided comparison data.
Instruments including: the Amphetamine Withdrawal Questionnaire, a modified version of the Cocaine Selective Severity Assessment, Clinical Global Impression scale and the St Mary's Hospital Sleep Questionnaire were completed daily for the first 3 weeks of abstinence.
Methamphetamine withdrawal severity declined from a high initial peak within 24 hours of the last use of amphetamines reducing to near control levels by the end of the first week of abstinence (the acute phase). The acute phase of amphetamine withdrawal was characterized by increased sleeping and eating, a cluster of depression-related symptoms and less severely, anxiety and craving-related symptoms. Following the acute withdrawal phase most withdrawal symptoms remained stable and at low levels for the remaining 2 weeks of abstinence.
This study has provided evidence of a methamphetamine withdrawal syndrome that can be categorized into two phases, the acute phase lasting 7-10 days during which overall symptom severity declined in a linear pattern from a high initial peak, and a subacute phase lasting at least a further 2 weeks.

  • Source
  • [Show abstract] [Hide abstract]
    ABSTRACT: The Criminal Codes in Queensland and Western Australia both require a two-stage test to be satisfied for an accused person to avail of an insanity defence. As also occurs in most other jurisdictions, the insanity defence does not apply in cases where the accused was intentionally intoxicated. In R v Clough [2010] QCA 120 the Queensland Court of Appeal dismissed an appeal from a conviction in which the accused murdered his wife whilst was he was actively psychotic following intentional amphetamine use more than 24 hours earlier. After considering extensive case authority and the construction of the amended Criminal Code provisions relating to intoxication, the Court of Appeal emphasised that any effect of intentional intoxication, whether transient or more prolonged, will deny an accused an unsoundness of mind defence. This case commentary considers the pharmacology of amphetamines and the often difficult distinction between amphetamine intoxication and amphetamine-induced psychosis is discussed.
    Psychiatry Psychology and Law 11/2012; 19(5):615-645. DOI:10.1080/13218719.2012.738022 · 0.35 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: Objective: Research suggests several possible associations among methamphetamine abuse, psychotic symptoms, depression, and posttraumatic stress disorder (PTSD), but the exact nature and clinical significance of these associations is unclear. Individuals who abuse methamphetamine increasingly present in hospital emergency rooms with acute psychiatric symptoms. The aim of this study was to identify patterns of depressive symptoms and explore predictors of acute versus sustained depressive symptoms in individuals who abuse methamphetamine and who have had psychotic symptoms. Methods: This longitudinal study, conducted in Vancouver, British Columbia, included 295 participants with methamphetamine use disorder who were seeking psychiatric help for depressive or psychotic symptoms, assessed at baseline and monthly for 6 months. Measures included substance use (including frequency, quantity, and route of administration), family history of psychosis and depression, trauma exposure, and PTSD symptoms. Results: Trajectory analyses on depressive symptoms revealed two profiles of depression: one with more severe and sustained depressive symptoms and one with decreasing and lower levels of depressive symptoms. Group comparisons showed that those with more severe and persistent depressive symptoms had more family history of depression ( p < .05), more years of alcohol and cocaine abuse ( p < .01), more traumatic events ( p < .001), and more PTSD symptoms ( p < .001). Logistic regression suggested that the strongest predictors of belonging to the high depression group were more severe psychotic symptoms at baseline (odds ratio [OR] = 2.03, p < .001), followed by quantity of methamphetamine used in the month preceding baseline (OR = 1.13, p < .05), severity of PTSD symptoms at baseline (OR = 1.07, p < .001), and the frequency of drug injection (OR = 1.25, p < .05). Conclusions: Our results are similar to those of other studies suggesting that depression and psychosis often coexist and that the intensity of methamphetamine abuse is linked to the severity of the depressive symptoms. The individuals who took part in this study had many coexisting problems, such as PTSD symptoms, polysubstance abuse, depression, and psychosis. In fact, depression, psychosis, PTSD, and substance abuse appeared to be intertwined in their development and expression. A more comprehensive treatment program to help individuals with multiple coexisting psychiatric and substance misuse issues is needed.
    Journal of Dual Diagnosis 05/2013; 9(2):115-122. DOI:10.1080/15504263.2013.778930 · 0.80 Impact Factor

Full-text (2 Sources)

Available from
May 16, 2014